LEMAITRE VASCULAR, INC. Additional Paid in Capital, Common Stock
LEMAITRE VASCULAR, INC. (LMAT) had Additional Paid in Capital, Common Stock of $236.16 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-05
- 2026-06-30: Additional Paid in Capital, Common Stock $236.16M.
- 2026-03-31: Additional Paid in Capital, Common Stock $233.45M.
- 2025-12-31: Additional Paid in Capital, Common Stock $228.41M.
- 2025-09-30: Additional Paid in Capital, Common Stock $224.15M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-06-30 | $236.16M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $233.45M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $228.41M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $224.15M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $220.82M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $217.12M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $213.76M 10-K · filed 2026-02-26 |
| 2024-09-30 | $210.75M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $208.69M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $206.35M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $200.75M 10-K · filed 2025-02-28 |
| 2023-09-30 | $198.25M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $196.94M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $192.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $189.27M 10-K · filed 2024-02-29 |
| 2022-09-30 | $186.80M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $184.60M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $183.31M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $181.63M 10-K · filed 2023-03-01 |
| 2021-09-30 | $179.07M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $119.29M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $117.24M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $114.92M 10-K · filed 2022-02-28 |
| 2020-09-30 | $109.64M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $107.79M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $106.95M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $105.93M 10-K · filed 2021-03-12 |
| 2019-09-30 | $103.67M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $100.89M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $99.67M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $98.44M 10-K · filed 2020-03-12 |
| 2018-09-30 | $97.73M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $95.12M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $94.04M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $93.13M 10-K · filed 2019-03-11 |
| 2016-12-31 | $85.38M 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |